Mar 26, 2026 08:35AM
Mar 25, 2026 04:02PM
Mar 25, 2026 12:38PM
Mar 2, 2026 05:08PM
Feb 26, 2026 04:01PM
Feb 24, 2026 09:05AM
Feb 5, 2026 02:04PM Denali shares clinical data on enzyme treatments for rare diseases
Feb 5, 2026 02:00PM
Jan 29, 2026 04:00PM
Jan 29, 2026 04:00PM
Jan 15, 2026 04:22AM
Jan 7, 2026 12:41AM
Jan 6, 2026 08:04AM
Jan 6, 2026 08:00AM Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome
Dec 30, 2025 09:57AM
Dec 30, 2025 08:00AM
Dec 30, 2025 08:00AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM
Dec 4, 2025 07:00AM
Nov 17, 2025 09:28AM Stifel Reiterates Buy Rating on Denali Therapeutics Inc. (DNLI)
Nov 6, 2025 04:01PM
Nov 6, 2025 04:00PM
Nov 6, 2025 04:00PM
Oct 15, 2025 07:25AM
Oct 14, 2025 07:05AM
Oct 13, 2025 04:01PM
Oct 13, 2025 04:01PM Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)
Aug 11, 2025 04:01PM
Jul 7, 2025 10:13AM
Jul 7, 2025 08:03AM
Jul 7, 2025 08:00AM
May 6, 2025 04:01PM
Jan 28, 2020 09:23AM

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All